Skip to main content
. 2019 Mar 5;9:88. doi: 10.3389/fonc.2019.00088

Table 4.

Cytogenetic profile of IM Resistant CML-CP patients.

Sl. No Recurrent karyotype No. of cases
1 46,XY,t(9;22)(q34;q11)[20] 31
2 46,XX,t(9;22)(q34;q11)[20] 16
3 46,XY,t(9;22)(q34;q11)[10]/46,XY[10] 2
4 46,XY,t(9;22)(q34;q11)[14]/46,XY[6] 2
5 46,XY,t(9;22)(q34;q11)[16]/46,XY[4] 2
6 46,XX,t(9;22)(q34;q11)[12]/46,XX [8] 2
7 47,XY,t(9;22)(q34;q11),+der(22)t(9;22)[20] 1
8 47,XY,t(9;22)(q34;q11),+der(22)t(9;22)[10]/49,XY,+8,t(9;22)(q34;q11),+der(22)t(9;22),+21[7]/49,XY,t(9;22)(q34;q11),+der(22)t(9;22),+16,+21[3] 1
9 46,X,–Y,t(9;22)(q34;q11),+der(22)t(9;22)[11]/47,XY,t(9;22)(q34;q11), +der(22)t(9;22)[9] 1
10 45,X,–Y,t(9;22)(q34;q11) 2
11 47,XX,+8,t(9;22)(q34;q11)[20] 2
12 46,XX,t(9;22)(q34;q11),dup(16)(q24)[20] 1
13 Karyotype failure 12
RARE KARYOTYPE
14 46,XY,der(9)t(9;22)(q34.13;q11.23),ider(22)(p12)t(9;22)[7]/47,sl,+ider(22)[21]/48,sdl,+ider(22)[2] 1
15 46,XY,t(9;22)(q34.13;q11.23)[4]/46,–der(22)t(9;22),+ider(22)(p12) t(9;22)[4]/47,sdl1,+ider(22)[13]/48,sl,+der(22),+ider(22)[4]/47,sl,+8[5] 1
NOVEL KARYOTYPE
16 46,XX,t(9;22;16)(q34;q11;p11.2)[20] 1